Joint replacement surgery study for bleeding disorders
Part of Blood & lymphatic, Bones, joints & muscles clinical trials.
This study looks at how people with inherited bleeding disorders, like hemophilia, do after joint replacement surgery. Researchers want to learn what works best for managing bleeding during and after surgery to improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have a congenital bleeding disorder, such as Hemophilia A, Hemophilia B, von Willebrand disease, or another factor deficiency.
- You are scheduled to have a joint replacement surgery (like a hip or knee replacement).
- You are willing to sign a consent form to allow the study team to review your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue from joints affected by hemophilia to find new markers that could help understand and treat joint damage. It is for people with severe hemophilia who need a joint procedure like a fluid removal, synovectomy, or joint replacement.
This study checks how different care during and after joint replacement surgery affects bleeding. It focuses on people having their first hip or knee replacement who received a standard bleeding-control medicine (tranexamic acid).
This study checks joint health and bleeding risk in people with severe hemophilia A who are taking newer factor VIII treatments or emicizumab. It uses ultrasound and blood tests to see how well these therapies protect joints.
This study looks at whether a “blocking” procedure (embolization) can improve long-lasting joint inflammation caused by inherited bleeding disorders. It focuses on people with joint lining inflammation from repeated bleeding into the joint.
This study is looking at how well joint health can be tracked in people with severe hemophilia A who are receiving regular factor VIII treatment. It uses special markers in the blood and ultrasound to check for early joint changes.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
Hear when a new Prosthetic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.